Biotherapeutic approaches to target cancer stem cells

Journal of Stem Cells
|April 5, 2014
PubMed

Insights

Cancer stem cells (CSCs) drive tumor initiation and resistance. Targeting these rare cells with biotherapeutics like oncolytic viruses and antibodies offers a promising new strategy to improve cancer therapy efficacy.

Area of Science:

  • Oncology
  • Cancer Biology
  • Drug Discovery

Background:

  • The cancer stem cell (CSC) concept provides a new framework for understanding tumor biology and developing targeted therapies.
  • CSCs are believed to be responsible for tumor initiation, metastasis, and resistance to conventional treatments.
  • Despite their potential, critical aspects of CSCs, including their origin and role in metastasis, require further investigation.

Purpose of the Study:

  • To outline the cancer stem cell concept and its significance in cancer research.
  • To explore biotherapeutic strategies for targeting CSCs.
  • To highlight the need for novel approaches to improve anti-cancer therapy efficacy.

Main Methods:

  • Review of the cancer stem cell concept and its implications.
  • Discussion of various biotherapeutic approaches for CSC targeting.
  • Analysis of the role of CSCs in tumor initiation, metastasis, and treatment resistance.

Main Results:

  • CSCs play a crucial role in tumor initiation, metastasis, and resistance to radio/chemotherapy.
  • Biotherapeutic strategies, including oncolytic viruses, monoclonal antibodies, cytokines, and cytotoxic T lymphocytes, show potential for CSC targeting.
  • Further research is needed to fully understand CSCs and optimize therapeutic strategies.

Conclusions:

  • The cancer stem cell concept offers a novel avenue for cancer drug discovery and therapy.
  • Targeting CSCs is essential for improving the efficacy of anti-cancer treatments.
  • Biotherapeutic approaches represent a promising strategy for inhibiting CSCs and overcoming treatment resistance.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K